ESCI期刊Oncology in Clinical Practice 2024/2025影响因子:0.368 (ONCOL CLIN PRACT) (2450-1654). (ONCOLOGY)(肿瘤学)Emerging Sources

显示全部楼层 · 发表于 2025-3-23 18:43:42

Submitted on: 14 April 2002. Revised on: 29 April 2002. Accepted on: 16 May 2002. Oncology in Clinical Practice---VIA MEDICA

显示全部楼层 · 发表于 2025-3-23 22:10:39

Submitted on: 19 July 2019. Revised on: 01 September 2019. Accepted on: 21 September 2019. Oncology in Clinical Practice---VIA MEDICA

显示全部楼层 · 发表于 2025-3-24 04:00:48

Submitted on: 27 April 2013. Revised on: 26 May 2013. Accepted on: 03 June 2013. Oncology in Clinical Practice

显示全部楼层 · 发表于 2025-3-24 07:45:00

显示全部楼层 · 发表于 2025-3-24 11:38:11

Submitted on: 09 July 2010. Revised on: 07 August 2010. Accepted on: 01 September 2010. Oncology in Clinical Practice

显示全部楼层 · 发表于 2025-3-24 15:46:07

Submitted on: 18 October 2013. Revised on: 19 November 2013. Accepted on: 01 December 2013. Oncology in Clinical Practice

显示全部楼层 · 发表于 2025-3-24 19:42:19

显示全部楼层 · 发表于 2025-3-25 01:33:02

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-1 14:41
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved